For research use only. We do not sell to patients.
HDAC8/BRPF1-IN-1
CAS No. : 2484255-85-6
Biological Activity：HDAC8/BRPF1-IN-1 (Compound 23a) is a dual inhibitor of HDAC8 and BRPF1 with an IC50 of 443 nM against human HDAC8 and a Kd of 67 nM against human BRPF1. HDAC8/BRPF1-IN-1 shows low in vitro activity against HDAC1 and 6.
Research Area：Cancer
Targets：Epigenetic Reader Domain|HDAC
Related Small Molecules:RVX-297;BRD4 Inhibitor-19;UNC6349 (Ket2);Curcumin;GSK6853;Pivanex;GSK4028;Crotonoside;MPT0B390;SR-0813;Inobrodib;RSC133;Apabetalone;OF-1;I-CBP112;HDAC1/6-IN-1;HDAC/HSP90-IN-4;JPS014;A-485;HDAC-IN-4;PLX51107;FKBP12 PROTAC dTAG-7;I-BET151;HDAC-IN-27;GSK040;1-Alaninechlamydocin;SKLB-23bb;BRM/BRG1 ATP Inhibitor-4;Tacedinaline
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
